title: [The fibrinogen-fibrin-fibrinolysis system in rheumatoid arthritis].
abstract: The enzymatic, nonenzymatic and XIIa-dependent fibrinolysis was inhibited. In RA without systemic manifestations the main cause of appearance of soluble complexes of monomeric fibrins (SCMF) in the blood is a local activation of coagulation in the inflamed joint tissues. It is suggested that an increase of SCMF concentration in the blood in patients with RA is a reliable and dynamic index of the activity of the inflammatory process.
authors.forename: G A
authors.initials: GA
authors.lastname: Belitskaia
authors.forename: I A
authors.initials: IA
authors.lastname: Palienko
authors.forename: L I
authors.initials: LI
authors.lastname: Shevchenko
authors.forename: N E
authors.initials: NE
authors.lastname: Fedorova
mesh_terms: D000328:Adult; D000368:Aged; D001172:Arthritis, Rheumatoid / Q000097:blood* / Q000175:diagnosis / Q000628:therapy; D003131:Combined Modality Therapy; D005260:Female; D005337:Fibrin / Q000032:analysis*; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis; D005340:Fibrinogen / Q000032:analysis*; D005342:Fibrinolysis; D006801:Humans; D008297:Male; D008875:Middle Aged
chemical_list: D005338:Fibrin Fibrinogen Degradation Products; D005337:Fibrin; D005340:Fibrinogen
vernacular_title: Sistema fibrinogen-fibrin-fibrinoliz pri revmatoidnom artrite.